Hermed Capital Fund (the “Fund”) is a private equity fund that will invest primarily in healthcare industry around the world.

The Fund provides investors with direct investment exposure to healthcare assets around the world, which have the potential to deliver superior returns. The Fund will mainly focus on three sub-sectors including but not limited to pharmaceuticals, medical device & diagnostic, and medical service.

Private and unique deals can be accessed quickly through the strong personal industry connections of senior managers of the Fund.

The appropriate investment strategy will be applied throughout the Fund life, from investment origination to the exit, where partners strength in healthcare sector will be fully leveraged.

Additional to traditional alpha generated from financial engineering of a target investment, LPs of the Fund will provide its operational and technical expertise   as “catalyst” to create additional alpha for each target investment.

Multiple exit options for a pharmaceutical company and medical device manufacturer including IPO or a trade sale to pharmaceutical giants.